[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ciuffetti et al., 1990 - Google Patents

Effects of ticlopidine on the neurologic outcome and the hemorheologic pattern in the postacute phase of ischemic stroke: a pilot study

Ciuffetti et al., 1990

Document ID
7504601759287655846
Author
Ciuffetti G
Aisa G
Mercuri M
Lombardini R
Paltriccia R
Neri C
Senin U
Publication year
Publication venue
Angiology

External Links

Snippet

This double-blind pilot study observed the effects of a twenty-one day oral ticlopidine treatment (250 mg/twice daily) on the neurologic outcome and the hemorheologic pattern of 15 patients and 15 placebo-treated controls. Patients and controls (age range sixty-six to …
Continue reading at journals.sagepub.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Spaet et al. Defective platelets in essential thrombocythemia
Langer et al. Erythrocyte protoporphyrin
Taylor et al. Acid-base status in paediatric Plasmodium falciparum malaria
Loeliger et al. Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus?
Nelson et al. Heparin-induced thrombocytopenia
Ciuffetti et al. Effects of ticlopidine on the neurologic outcome and the hemorheologic pattern in the postacute phase of ischemic stroke: a pilot study
Ciuffetti et al. Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease: results of a double-blind placebo-controlled study
Chumbley Pseudohyperkalemia in acute myelocytic leukemia
Angelkort et al. Blood flow properties and walking performance in chronic arterial occlusive disease
MADERAZO et al. Polymorphonuclear leukocyte migration abnormalities and their significance in seriously traumatized patients
CA1218001A (en) Serum fibrinogen viscosity in clinical medicine
Nilsson et al. Bubble and membrane oxygenators—comparison of postoperative organ dysfunction with special reference to inflammatory activity
Burr Blood zinc in the spinal patient
Ward et al. Red blood cell deformability: effect of age and smoking
Feuring, A. Gutfleisch, A. Ganschow, E. Richter, H. Eichler, CE Dempfle, HC Tillmann, A. Schultz, M. Wehling Impact of plasmapheresis on platelet hemostatic capacity in healthy voluntary blood donors detected by the platelet function analyzer PFA-100™
Mišković et al. The Correlation between Iron Deficiency and Recurrent Aphthous Stomatitis: A Literature Review
Federici et al. Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity
Meleney et al. POST-TRANSFUSION REACTIONS: A REVIEW OF 280 TRANSFUSIONS PERFORMED IN THE WARDS OF PRESBYTERIAN HOSPITAL, NEW YORK CITY.
Robbins Effects of phenyl benzo-γ-pyrone derivatives (flavonoids) on blood cell aggregation: basis for a concept of mode of action
Hung et al. Alterations in erythrocyte rheology in patients with severe peripheral vascular disease: 1. cell volume dependence of erythrocyte rigidity
Kracke et al. Chronic Hemolytic anemia with autoagglutination and hyperglobulinemia; report of a fatal case
Faudskar Immune-Medicated Hemolytic Anemia
Seiffge et al. Effect of pentoxifylline on sickle cell thalassaemia: haemorheological and clinical results
Ciuffetti et al. Stable angina pectoris and controlled ischemia: what causes the abnormalities in whole blood filterability?
Nagakawa et al. Effect of idebenone on hemorheologic variables in geriatric patients with cerebral infarction